24 /100
LOW RISK
Score updated Jul 14, 2026

RARE — Ultragenyx Pharmaceutical Inc. Dilution Risk Tracker

Track RARE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RARE — Get alerts when the score changes →

As of July 14, 2026, Ultragenyx Pharmaceutical Inc. (RARE) has a DilutionWatch DilutionScore of 24/100, rated LOW dilution risk. Ultragenyx Pharmaceutical Inc. has a market capitalization of $2.36B, 98.49M shares outstanding, 297 institutional holders tracked. Key dilution vectors include approximately 12 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
22
💰 Cash Runway
40
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for RARE.
🔔 Track RARE — Get forecast alerts →

💹 Market Data

Market Cap$2.36B
Shares Outstanding98.49M
Float94.50M
Cash$743.03M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 12.5% shares (2026Q1 vs prior)
297 institutional holders · 113.36M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 8.38M shares
#2 BlackRock, Inc. 7.30M shares
#3 VANGUARD PORTFOLIO MANAGEMENT LLC 5.39M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest16.22M
Days to Cover3.6
% of Float17.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2014
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Mar 10, 2026
4 INSIDER TRANSACTION Mar 03, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for RARE Shareholders

Ultragenyx Pharmaceutical Inc. (RARE) has a DilutionScore of 24/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 14, 2026.

Cash runway is a key watch item: RARE has approximately 12 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for RARE in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for RARE alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track RARE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RARE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

LBTYA LBTYK AER AIG BABA

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for RARE
📊 RARE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 RARE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.